Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 3, 2024Expert Opinion on Therapeutic Patents

An updated patent review of TRPA1 antagonists (2020 – present)

View Full Paper
Ask AI
Bookmark
Share

Authors

RVRosa Maria VitaleLPLuciano De PetrocellisPAPietro Amodeo

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Vitale et al. (2024) studied this question.

synapsesocial.com/papers/68e6ba6ab6db64358763af45https://doi.org/10.1080/13543776.2024.2364798
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1REVIEW ARTICLE ON TRP CHANNELS IN PAIN MANAGEMENT SYSTEM2026
  2. 2Targeting TRPA1 with Novel Synthetic Compounds Based on Different Scaffolds to Reduce Acute and Chronic Pain2026 · 1 citations
  3. 3Discovery of Dual TRPA1 and TRPV1 Antagonists as Novel Therapeutic Agents for Pain2024 · 8 citations
  4. 4TR(i)P Goes On: Auxiliary TRP Channel Subunits?2024 · 2 citations
  5. 5TRPA1 as a Key Regulator of Keratinocyte Homeostasis and Inflammation in Human Skin2026